Is the radiopharmaceutical used in a Hepatobiliary Iminodiacetic Acid (HIDA) scan safe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Safety of Radiopharmaceuticals in HIDA Scans

  • The safety of radiopharmaceuticals used in HIDA scans is not directly addressed in the provided studies, which primarily focus on the diagnostic applications and interpretations of HIDA scans in various hepatobiliary conditions 1, 2, 3, 4, 5.
  • However, the fact that these studies discuss the use of HIDA scans in clinical practice without mentioning significant safety concerns suggests that the radiopharmaceuticals used are considered safe for diagnostic purposes 1, 3.
  • The studies highlight the effectiveness of HIDA scans in diagnosing and evaluating various hepatobiliary diseases, including acute cholecystitis, biliary obstruction, and congenital biliary anomalies 1, 2, 4.
  • The use of technetium-99m (Tc-99m) labeled iminodiacetic acid derivatives in HIDA scans is mentioned as a common practice, indicating a level of safety and efficacy associated with these radiopharmaceuticals 3, 5.

References

Research

Nuclear medicine hepatobiliary imaging.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2010

Research

HIDA scanning in gall-bladder disease.

The British journal of radiology, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.